Cancer cell-combatting lymphocytes, process for the production thereof and anticancer agents containing said lymphocytes

Abstract From the Canadian patent

This invention relates to a cancer cellcombatting lympocyte, a process for the production of such lymphocytes, and an anticancer drug containing the lymphocyte as an active ingredient. The lymphocytes have a glyco-related antigen which is derived from the cancer cells. The antigen is a cancer cell membrane component capable of combining with a lectin which can combine with a terminal galactose or a terminal Nacetylgalactosamine and which is isolated from a cancer cell membrane component with the lectin. These new lymphocytes effectively and specifically combat cancer cells and the anticancer agents contain the lymphocytes which use the immune response of the lymphocytes are proven effective.